Terms: = Endocrine gland cancer AND ETV5, P41161, 2119, ENSG00000244405, ERM AND Prognosis
6 results:
1. ANGPTL4 functions as an oncogene through regulation of the etv5/CDH5/AKT/MMP9 axis to promote angiogenesis in ovarian cancer.
Liu Y; Yang R; Zhang Y; Zhu Y; Bao W
J Ovarian Res; 2022 Dec; 15(1):131. PubMed ID: 36517864
[TBL] [Abstract] [Full Text] [Related]
2. Biological and prognostic value of etv5 in high-grade serous ovarian cancer.
Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
[TBL] [Abstract] [Full Text] [Related]
3. Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Song YS; Yoo SK; Kim HH; Jung G; Oh AR; Cha JY; Kim SJ; Cho SW; Lee KE; Seo JS; Park YJ
Endocr Relat Cancer; 2019 Jun; 26(6):629-641. PubMed ID: 30999281
[TBL] [Abstract] [Full Text] [Related]
4. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract] [Full Text] [Related]
5. Expression and prognostic significance of 14-3-3sigma and erm family protein expression in periampullary neoplasms.
Hustinx SR; Fukushima N; Zahurak ML; Riall TS; Maitra A; Brosens L; Cameron JL; Yeo CJ; Offerhaus GJ; Hruban RH; Goggins M
Cancer Biol Ther; 2005 May; 4(5):596-601. PubMed ID: 15908786
[TBL] [Abstract] [Full Text] [Related]
6. CA 19-9 serum course and prognosis of pancreatic cancer.
Safi F; Schlosser W; Falkenreck S; Beger HG
Int J Pancreatol; 1996 Dec; 20(3):155-61. PubMed ID: 9013275
[TBL] [Abstract] [Full Text] [Related]
